
Symbioteq
Medical technical consultants and education.
Related Content
We make the complex things easier, all the way from idea to market. Development of medical devices and pharmaceuticals is a complex and demanding business. Since small and medium-sized companies seldom have all the necessary expertise in all aspects of product development, many have to rely on several different partners for the required specialist expertise. Symbioteq Kvalitet AB and Key2Compliance® were founded as two independent companies during the 1990s. Symbioteq focused on consulting in the area of Regulatory and Quality for medical devices and Key2Compliance® soon became a leading company in Training and Education in the field of Current Good Manufacturing Practice (cGMP). After several years of cooperation, the two companies merged in 2020 and formed a joint company called Key2Compliance®, a company within the Symbioteq group. Key2Compliance® offers complete and optimized solutions for companies working with development of pharmaceuticals, medical devices, diagnostics, fillers and combination products. Thanks to our broad competence and extensive experience, we guide our customers through all stages of the process, from idea to market. It does not matter what your needs are – RA, QA, GXP, regulations, registrations, biological evaluations or clinical development – everything is within our expertise. In addition, we can offer a first-class Training and Education program for both Pharma and Medical Device Companies in Regulatory requirements, Quality systems and GMP. This makes the journey with us a learning experience, where we learn from each other and develop together during the process. Key2Compliance® has all the keys required for a successful product development process. With our strengthened offering, it is our ambition that Key2Compliance® will become the foremost partner for pharmaceutical and medical device companies, not only in Sweden but at an international level. Key2Compliance® has offices in Stockholm, Lund and Gothenburg.